PNC Financial Services Group
KNSA icon

PNC Financial Services Group’s Kiniksa Pharmaceuticals KNSA Stock Holding History

PNC Financial Services Group’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$111K Sell
1,742
-23
-1% -$1.19K ﹤0.01% 2850
2026
Q1 		$85K Sell
1,765
-157
-8% -$6.96K ﹤0.01% 2921
2025
Q4 		$79.3K Buy
1,922
+21
+1% +$842 ﹤0.01% 2949
2025
Q3 		$73.8K Sell
1,901
-1,587
-45% -$51.6K ﹤0.01% 2990
2025
Q2 		$96.5K Sell
3,488
-1,055
-23% -$26.9K ﹤0.01% 2730
2025
Q1 		$101K Sell
4,543
-242
-5% -$4.98K ﹤0.01% 2653
2024
Q4 		$94.6K Buy
4,785
+9
+0.2% +$205 ﹤0.01% 2708
2024
Q3 		$119K Sell
4,776
-355
-7% -$8.65K ﹤0.01% 2560
2024
Q2 		$95.8K Buy
5,131
+5,123
+64,038% +$96K ﹤0.01% 2657
2024
Q1 		$158 Buy
8
+2
+33% +$39 ﹤0.01% 4624
2023
Q4 		$105 Buy
+6
New +$99 ﹤0.01% 4518

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

PNC Financial Services Group's KNSA Position: Q2 2026 in Review

PNC Financial Services Group reduced its Kiniksa Pharmaceuticals (KNSA) stake by 1.3% in Q2 2026, selling an estimated $1.19K and leaving 1,742 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #2850.

PNC Financial Services Group first reported a position in KNSA in Q4 2023 and has held it in 11 quarters since. The position peaked at $119K in Q3 2024. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • PNC Financial Services Group held 1,742 shares of Kiniksa Pharmaceuticals worth $111K as of Q2 2026.
  • PNC Financial Services Group sold 23 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $1.19K.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #2850 holding.
  • PNC Financial Services Group first reported a position in Kiniksa Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • PNC Financial Services Group's Kiniksa Pharmaceuticals position peaked at $119K in Q3 2024.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.